- Report
- July 2022
- 100 Pages
Global
From €2613EUR$2,750USD£2,247GBP
- Report
- July 2022
- 100 Pages
Global
From €2613EUR$2,750USD£2,247GBP
- Report
- July 2022
- 100 Pages
Global
From €2613EUR$2,750USD£2,247GBP
- Report
- January 2024
- 87 Pages
From €3373EUR$3,550USD£2,901GBP
- Report
- January 2024
- 86 Pages
From €3373EUR$3,550USD£2,901GBP
- Report
- October 2023
- 123 Pages
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
- Report
- March 2022
- 390 Pages
Global
From €3026EUR$3,185USD£2,603GBP
€4323EUR$4,550USD£3,718GBP
- Report
- March 2022
- 320 Pages
North America
From €1995EUR$2,100USD£1,716GBP
€2850EUR$3,000USD£2,452GBP
- Report
- February 2024
- 81 Pages
Saudi Arabia
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 85 Pages
China
From €4513EUR$4,750USD£3,882GBP
- Report
- April 2023
- 80 Pages
Italy
From €4513EUR$4,750USD£3,882GBP
- Report
- April 2023
- 115 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- April 2023
- 115 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- April 2023
- 110 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- April 2023
- 100 Pages
Spain
From €4513EUR$4,750USD£3,882GBP
- Report
- April 2023
- 75 Pages
South Africa
From €4513EUR$4,750USD£3,882GBP
- Report
- April 2023
- 68 Pages
Canada
From €4513EUR$4,750USD£3,882GBP
- Report
- April 2023
- 85 Pages
Argentina
From €4513EUR$4,750USD£3,882GBP
- Report
- April 2023
- 68 Pages
Japan
From €4513EUR$4,750USD£3,882GBP
- Report
- August 2022
- 75 Pages
United States
From €4513EUR$4,750USD£3,882GBP
The Cardiac Valve market is a segment of the Cardiovascular Devices industry, which includes a range of products used to diagnose and treat heart conditions. Cardiac valves are used to regulate the flow of blood through the heart, and can be either mechanical or biological. Mechanical valves are typically made of metal and are designed to last for many years, while biological valves are made of animal tissue and are designed to be replaced over time. Both types of valves are used to treat a variety of heart conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation.
The Cardiac Valve market is highly competitive, with a number of companies offering a range of products. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Other companies in the market include CryoLife, Symetis, and Neovasc. Show Less Read more